Advances in the allogeneic transplantation for thalassemia.
about
Hematopoietic stem cell transplantation for people with ß-thalassaemia majorCurrent and future alternative therapies for beta-thalassemia majorAlternative donor transplant of benign primary hematologic disordersHematopoietic stem cell transplantation in thalassemia and sickle cell anemiaEscalating doses of donor lymphocytes for incipient graft rejection following SCT for thalassemia.Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel.A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in ThailandTherapeutic effects of induced pluripotent stem cells in chimeric mice with β-thalassemia.Quantitatively different red cell/nucleated cell chimerism in patients with long-term, persistent hematopoietic mixed chimerism after bone marrow transplantation for thalassemia major or sickle cell disease.Hematopoietic stem cell transplantation for people with ß-thalassaemia major.Cost utility analysis of reduced intensity hematopoietic stem cell transplantation in adolescence and young adult with severe thalassemia compared to hypertransfusion and iron chelation program.Therapeutic levels of fetal hemoglobin in erythroid progeny of β-thalassemic CD34+ cells after lentiviral vector-mediated gene transfer.Critical role of sensitized serum in rejection of allogeneic bone marrow cells.Pretransplant immunosuppression followed by reduced-toxicity conditioning and stem cell transplantation in high-risk thalassemia: a safe approach to disease controlGuidelines for the Standard Monitoring of Patients With Thalassemia: Report of the Thalassemia Longitudinal Cohort.Haematopoietic stem cell transplantation in Nigerian sickle cell anaemia children patientsCorrection of beta-thalassemia major by gene transfer in haematopoietic progenitors of pediatric patients.Umbilical cord blood transplantation for children with thalassemia and sickle cell disease.Chemoselection of allogeneic HSC after murine neonatal transplantation without myeloablation or post-transplant immunosuppression.Hemoglobin research and the origins of molecular medicine.Relationship between mixed chimerism and rejection after bone marrow transplantation in thalassaemia.Cardiac and cardiovascular consequences after haematopoietic stem cell transplantation.Mixed chimerism in SCT: conflict or peaceful coexistence?Regional consensus opinion for the management of Beta thalassemia major in the Arabian Gulf areaType 1 regulatory T cells are associated with persistent split erythroid/lymphoid chimerism after allogeneic hematopoietic stem cell transplantation for thalassemia.One-Step Biallelic and Scarless Correction of a β-Thalassemia Mutation in Patient-Specific iPSCs without Drug Selection.Gene therapy for β-thalassaemia: the continuing challenge.Clinical tolerance in allogeneic hematopoietic stem cell transplantation.Current and future approaches to treat graft failure after allogeneic hematopoietic stem cell transplantation.Concise review: stem cell-based approaches to red blood cell production for transfusion.Analysis of protein profiling studies of β-thalassemia/Hb E disease.Thalassaemia in children: from quality of care to quality of life.Increasing prevalence of thalassemia in America: Implications for primary care.Impact of prohepcidin levels and iron parameters on early post-transplantation toxicities.Is ABO mismatch another risk factor for allogeneic hematopoietic stem cell transplantation in pediatric thalassemic patients?Impact of a change in protected environment on the occurrence of severe bacterial and fungal infections in children undergoing hematopoietic stem cell transplantation.Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies.Infectious complications following allogeneic stem cell transplantation by using anti-thymocyte globulin-based myeloablative conditioning regimens in children with hemoglobinopathies.Musings on genome medicine: enzyme-replacement therapy of the lysosomal storage diseases.Iron overload in patients undergoing hematopoietic stem cell transplantation.
P2860
Q24193101-59EF8F11-2E73-45D7-98DA-BB763B05F041Q26750906-96E14802-B6C2-4873-A794-973C666AEE39Q26823398-54AC4ECE-3CAD-4C60-81F6-8C8610AF3A9FQ26824116-94B1CB5B-A419-42AA-89E5-DEA3A98CF082Q33386915-1A9D7D86-50A3-4E01-8BF1-A1DC3F23EC88Q33558770-9B0108B8-DE87-44C0-8D81-8C3A52FA3BB6Q33633474-9E2752D1-B129-46FB-ADAD-D0AB7429C245Q33978886-CA5C9B05-F29E-423C-A8DB-9B3ED5C79AB5Q34451588-99DAD3D9-F4E2-4505-BC13-DC872997D509Q34546216-D2D2ECA0-231C-4A1E-8CC4-96C4D229DD06Q34573919-C0E282BE-C197-4C87-9EA8-8D1CA970F989Q34707143-3883044A-EDF3-44FE-9366-AB0219325F2CQ34868407-010B2E99-88CB-408E-AF6D-885AB740EED5Q35600557-3DB24609-F306-4997-A0C4-DBAB232D401EQ35881019-9185F018-D8DE-4262-B1B7-DC1F85F9030EQ35898546-FAA8217C-46E7-4DDB-AAF2-A4B19D9B5E9CQ36039318-74FCD2DB-3EEC-4F3C-80D7-DB967B1899EDQ36090062-2D9473FF-169F-44FF-873F-0B81432D951AQ36401055-277F9027-81FF-4E55-9D7C-43D1D92CE785Q36969792-9B0C6B60-65EF-4451-8670-EE7506335958Q37062428-F9EF70CC-2809-4F7D-BA3C-24DAA3C1DA13Q37145279-BCB3C59D-FDD3-43D8-9AE3-A1859554338AQ37228383-3D8A8666-BC53-46C6-BED5-B156D6A70E56Q37359617-4358DADB-57C4-40BD-B595-E91255597C12Q37369938-3716FFB2-B88E-4823-89CE-900C0FAEF83BQ37718157-BE094B83-EED4-4C40-BCAD-94412299B45BQ37795125-F4F91C6B-18CC-4652-BE35-1190B898A978Q37864697-20F74933-8E5C-46D0-A517-A922F68116FDQ38155240-109A8EE7-0329-4370-A985-EAFAB3A9B560Q38173213-D0E123F7-F8DC-4122-8AE9-967698EA6A2DQ38443865-DFE3F00F-416D-4879-887F-4A7554A90492Q38569638-2A3A0039-23FB-4E73-887B-AF1D5200232FQ38626123-5D94CB73-F1A2-4AE5-B9E4-C580A2A10AB3Q40312709-F0319A54-D49C-4C92-9D97-84E8B84F8B5AQ40756603-57EAC460-FAF2-4A94-AC62-4CAB4DF4A750Q40994236-1A064252-8A87-4B9D-8D81-75C92047EFFCQ41010661-4F8E8165-2703-4B7B-B199-5107189D3F38Q41489129-9B81CA6A-54B1-480F-8966-2BA293BF13A5Q41815369-586D5158-BE57-4419-B8E6-59844A3287A1Q41914835-CE216F71-E4A7-4004-9BDC-85D4DCDF27D3
P2860
Advances in the allogeneic transplantation for thalassemia.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Advances in the allogeneic transplantation for thalassemia.
@en
Advances in the allogeneic transplantation for thalassemia.
@nl
type
label
Advances in the allogeneic transplantation for thalassemia.
@en
Advances in the allogeneic transplantation for thalassemia.
@nl
prefLabel
Advances in the allogeneic transplantation for thalassemia.
@en
Advances in the allogeneic transplantation for thalassemia.
@nl
P1433
P1476
Advances in the allogeneic transplantation for thalassemia.
@en
P2093
Guido Lucarelli
Javid Gaziev
P356
10.1016/J.BLRE.2007.10.001
P577
2007-11-26T00:00:00Z